
James D. Anderson
Examiner (ID: 3413, Phone: (571)272-9038 , Office: P/1629 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1629, 1614 |
| Total Applications | 1671 |
| Issued Applications | 822 |
| Pending Applications | 124 |
| Abandoned Applications | 752 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
| 15/899160 | METHOD AND COMPOSITIONS FOR TREATING DYSTROPHIES AND MYOTONIA | Feb 18, 2018 | Abandoned |
Array
(
[id] => 15782367
[patent_doc_number] => 10624885
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-21
[patent_title] => Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition
[patent_app_type] => utility
[patent_app_number] => 15/895783
[patent_app_country] => US
[patent_app_date] => 2018-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 45
[patent_no_of_words] => 10615
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15895783
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/895783 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | Feb 12, 2018 | Issued |
Array
(
[id] => 13354495
[patent_doc_number] => 20180228787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => AMELIORATION OF CERTAIN DEFICIENCIES DUE TO STROKE
[patent_app_type] => utility
[patent_app_number] => 15/895881
[patent_app_country] => US
[patent_app_date] => 2018-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2858
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15895881
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/895881 | Amelioration of certain deficiencies due to stroke | Feb 12, 2018 | Issued |
Array
(
[id] => 13354377
[patent_doc_number] => 20180228728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => DOSAGE FORM FOR ADMINISTRATION OF OPIOID ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 15/894377
[patent_app_country] => US
[patent_app_date] => 2018-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6015
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15894377
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/894377 | DOSAGE FORM FOR ADMINISTRATION OF OPIOID ANTAGONISTS | Feb 11, 2018 | Abandoned |
Array
(
[id] => 16663851
[patent_doc_number] => 10933073
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-02
[patent_title] => Compositions and methods comprising a psilocybin derivative
[patent_app_type] => utility
[patent_app_number] => 15/893562
[patent_app_country] => US
[patent_app_date] => 2018-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21437
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15893562
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/893562 | Compositions and methods comprising a psilocybin derivative | Feb 8, 2018 | Issued |
Array
(
[id] => 15451091
[patent_doc_number] => 20200038369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => RESCUE TREATMENT OF POST OPERATIVE NAUSEA AND VOMITING
[patent_app_type] => utility
[patent_app_number] => 16/485008
[patent_app_country] => US
[patent_app_date] => 2018-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3940
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16485008
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/485008 | Rescue treatment of post operative nausea and vomiting | Feb 8, 2018 | Issued |
Array
(
[id] => 13339559
[patent_doc_number] => 20180221319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => METHODS OF TREATING SEIZURE DISORDERS AND PRADER-WILLI SYNDROME
[patent_app_type] => utility
[patent_app_number] => 15/891785
[patent_app_country] => US
[patent_app_date] => 2018-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29651
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15891785
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/891785 | METHODS OF TREATING SEIZURE DISORDERS AND PRADER-WILLI SYNDROME | Feb 7, 2018 | Abandoned |
Array
(
[id] => 15751191
[patent_doc_number] => 10617678
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-14
[patent_title] => Treatment of restenosis using temsirolimus
[patent_app_type] => utility
[patent_app_number] => 15/890857
[patent_app_country] => US
[patent_app_date] => 2018-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 33
[patent_no_of_words] => 11142
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15890857
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/890857 | Treatment of restenosis using temsirolimus | Feb 6, 2018 | Issued |
Array
(
[id] => 12786214
[patent_doc_number] => 20180153907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => Ciclesonide for the Treatment of Airway Disease in Horses
[patent_app_type] => utility
[patent_app_number] => 15/889307
[patent_app_country] => US
[patent_app_date] => 2018-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9692
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15889307
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/889307 | Ciclesonide for the treatment of airway disease in horses | Feb 5, 2018 | Issued |
Array
(
[id] => 13328355
[patent_doc_number] => 20180215715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => SOLID STATE FORMS OF NETARSUDIL MESYLATE
[patent_app_type] => utility
[patent_app_number] => 15/886024
[patent_app_country] => US
[patent_app_date] => 2018-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4719
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15886024
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/886024 | Solid state forms of netarsudil mesylate | Jan 31, 2018 | Issued |
Array
(
[id] => 13867403
[patent_doc_number] => 20190030042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => Method for Treating Dementia with Lewy Bodies
[patent_app_type] => utility
[patent_app_number] => 15/886379
[patent_app_country] => US
[patent_app_date] => 2018-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2607
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15886379
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/886379 | Method for Treating Dementia with Lewy Bodies | Jan 31, 2018 | Abandoned |
Array
(
[id] => 16183481
[patent_doc_number] => 10716773
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-21
[patent_title] => Compositions comprising 15-HEPE and methods of treating or preventing cancer and neurologic disease
[patent_app_type] => utility
[patent_app_number] => 15/879508
[patent_app_country] => US
[patent_app_date] => 2018-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7401
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15879508
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/879508 | Compositions comprising 15-HEPE and methods of treating or preventing cancer and neurologic disease | Jan 24, 2018 | Issued |
Array
(
[id] => 14975311
[patent_doc_number] => 10441538
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-15
[patent_title] => Liquid naloxone spray
[patent_app_type] => utility
[patent_app_number] => 15/876553
[patent_app_country] => US
[patent_app_date] => 2018-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 17154
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15876553
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/876553 | Liquid naloxone spray | Jan 21, 2018 | Issued |
Array
(
[id] => 12786091
[patent_doc_number] => 20180153866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => TREATMENT OF SUNBURN USING ANALGESICS AND ANTIHISTAMINES
[patent_app_type] => utility
[patent_app_number] => 15/870654
[patent_app_country] => US
[patent_app_date] => 2018-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10700
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15870654
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/870654 | Treatment of sunburn using analgesics and antihistamines | Jan 11, 2018 | Issued |
Array
(
[id] => 13311453
[patent_doc_number] => 20180207263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => TREATMENT OF CANCER WITH NALTREXONE
[patent_app_type] => utility
[patent_app_number] => 15/867177
[patent_app_country] => US
[patent_app_date] => 2018-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4876
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15867177
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/867177 | TREATMENT OF CANCER WITH NALTREXONE | Jan 9, 2018 | Abandoned |
Array
(
[id] => 15631881
[patent_doc_number] => 10588908
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-17
[patent_title] => Methods of treating pediatric cancers
[patent_app_type] => utility
[patent_app_number] => 15/861017
[patent_app_country] => US
[patent_app_date] => 2018-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 14
[patent_no_of_words] => 34838
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15861017
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/861017 | Methods of treating pediatric cancers | Jan 2, 2018 | Issued |
Array
(
[id] => 14501089
[patent_doc_number] => 20190194199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => Pharmaceutically Acceptable Salt of EGFR Inhibitor, Crystal Form Thereof, Preparation Method Therefor and Application Thereof
[patent_app_type] => utility
[patent_app_number] => 16/329544
[patent_app_country] => US
[patent_app_date] => 2018-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7284
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16329544
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/329544 | Pharmaceutically acceptable salt of EGFR inhibitor, crystal form thereof, preparation method therefor and application thereof | Jan 1, 2018 | Issued |
Array
(
[id] => 12857713
[patent_doc_number] => 20180177745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => Application Of R-ketamine And Salt Thereof As Pharmaceuticals
[patent_app_type] => utility
[patent_app_number] => 15/849698
[patent_app_country] => US
[patent_app_date] => 2017-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10897
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15849698
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/849698 | Application of R-ketamine and salt thereof as pharmaceuticals | Dec 20, 2017 | Issued |
Array
(
[id] => 12562518
[patent_doc_number] => 10016407
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2018-07-10
[patent_title] => Pharmaceutical compositions and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 15/849575
[patent_app_country] => US
[patent_app_date] => 2017-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 22
[patent_no_of_words] => 29980
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15849575
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/849575 | Pharmaceutical compositions and methods of using the same | Dec 19, 2017 | Issued |
Array
(
[id] => 13618565
[patent_doc_number] => 20180360834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES
[patent_app_type] => utility
[patent_app_number] => 15/846356
[patent_app_country] => US
[patent_app_date] => 2017-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7038
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15846356
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/846356 | QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES | Dec 18, 2017 | Abandoned |